α1-Adrenergic receptor subtypes in human detrusor

Journal of Urology

Volumn 160, Issue 3 I, 1998, Pages 937-943

  Malloy, Brian J ^a   Price, David T ^a   Price, R Reyn ^a   Bienstock, Alan M ^a   Dole, Mark K ^a   Funk, Bonnie L ^a   Rudner, Xiaowen L ^a   Richardson, Charlene D ^a   Donatucci, Craig F ^a   Schwinn, Debra A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adrenergic receptors; Bladder; Detrusor; Human; Rat; Smooth muscle

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; RECEPTOR SUBTYPE; MESSENGER RNA;

ADULT; AGED; ALPHA ADRENERGIC STIMULATION; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BLADDER NECK STENOSIS; DETRUSOR MUSCLE; FEMALE; HUMAN; HUMAN TISSUE; LIGAND BINDING; MALE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; RADIOASSAY; RAT; REPRODUCIBILITY; ANIMAL; BLADDER; CHEMISTRY; CLASSIFICATION; GENETICS; SMOOTH MUSCLE; SPRAGUE DAWLEY RAT;

ANIMALS; HUMANS; MALE; MUSCLE, SMOOTH; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; RNA, MESSENGER; URINARY BLADDER;

EID: 0032322466     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62836-2     Document Type: Article

References (39)

1. Steers, W. D., Barrett, D. M. and Wein, A. J.: Voiding dysfunction: diagnosis, classification, and management. In: Adult and Pediatric Urology, Third Edition. Edited by J. Y. Gillenwater et al. Mosby-Year Book, Inc.: St. Louis, pp. 1220-1325, 1996.
2. Zderic, S. A., Levin, R. M. and Wein, A. J.: Voiding function: relevant anatomy, physiology, pharmacology, and molecular aspects. In: Adult and Pediatric Urology, Third Edition. Edited by J. Y. Gillenwater et al. Mosby-Year Book, Inc.: St. Louis, pp. 1159-1219, 1996.
3. Gosling, J. A. and Dixon, J. S.: Detrusor morphology in relation to bladder outflow obstruction and instability. In: Benign Prostatic Hypertrophy. Edited by F. Hinman. Springer-Verlag: Berlin, pp. 666-71, 1983.
4. Caine, M., Raz, S. and Zeigler, M.: Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck. Br. J. Urol., 47: 193, 1975.
5. Shapiro, E., Hartanto, V., Becich, M. J. and Lepor, H.: The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic BPH. J. Urol., 147: 1293, 1992.
6. Chapple, C. R.: Alpha-adrenergic blocking drugs in bladder outflow obstruction: what potential has alpha 1-adrenoceptor selectivity? Br. J. Urol., 1: 47, 1995.
7. Caine, M.: Alpha-adrenergic blockers for the treatment of benign prostatic hyperplasia. Urol. Clin. N. Am., 17: 641, 1990.
8. Kawabe, K. and Niijima, T.: Use of an alpha 1-blocker, YM-12617, in micturition difficulty. Urol. Int., 42: 280, 1987.
9. Lepor, H., Auerbach, S., Puras, B. A., Narayan, P., Soloway, M., Lowe, F., Moon, T., Leifer, G. and Madsen, P.: A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. J. Urol., 148: 1467, 1992.
10. Reuther, K. and Aagaard, J.: Alpha-adrenergic blockade in diagnosis of detrusor instability secondary to infravesical obstruction. Urol. Int., 39: 312, 1984.
11. Matyus, P. and Horvath, K.: α-Adrenergic approach in the medical management of benign prostatic hyperplasia. Med. Res. Rev., 17: 523, 1997.
12. Serels, S. and Stein, M.: Prospective study comparing hyoscyamine, doxazosin, and combination therapy for the treatment of urgency and frequency in women. Neurourol. Urodynam., 17: 31, 1998.
13. Chapple, C. R. and Smith, D.: The pathophysiological changes in the bladder obstructed by benign prostatic hyperplasia. Br. J. Urol., 73: 117, 1994.
14. Steers, W. D. and De Groat, W.: Effect of bladder outlet obstruction on micturition reflex pathways in the rat. J. Urol., 140: 864, 1988.
15. Steers, W. D., Albo, M. and Tuttle, J. B.: Calcium channel antagonists prevent urinary bladder growth and neuroplasticity following mechanical stress. Am. J. Physiol., 266: R20, 1994.
16. 1-adrenergic receptors: sequence corrections and direct comparison with other species homologues. J. Pharmacol. Exp. Ther., 272: 134, 1995.
17. Hieble, J. P., Bylund, D. B., Clarke, D. E., Eikenburg, D. C., Langer, S. Z., Lefkowitz, R. J., Minneman, K. P. and Ruffolo, R. J.: International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update. Pharmacol. Rev., 47: 267, 1995.
18. Price, D., Schwinn, D., Lomasney, J., Allen, L., Caron, M. and Lefkowitz, R.: Identification, quantification, and localization of mRNA for three distinct alpha 1-adrenergic receptor subtypes in human prostate. J. Urol., 150: 546, 1993.
19. 1a subtype. Mol. Pharmacol., 45: 703, 1994.
20. Lepor, H., Zhang, W., Kobayashi, S., Tang, R., Wang, B. and Shapiro, E.: A comparison of the binding and functional properties of alpha-1 adrenoceptors and area density of smooth muscle in the human and canine. J. Pharmacol. Exp. Ther., 270: 722, 1994.
21. Muramatsu, I., Oshita, M., Ohmura, T., Kigoshi, S., Akino, H., Gobara, M. and Okada, K.: Pharmacological characterization of alpha 1-adrenoceptor subtype in the human prostate: functional and binding studies. Br. J. Urol., 74: 572, 1994.
22. 1-adrenoceptors in human prostate: implications for adrenoceptor classification. Mol. Pharmacol., 49: 209, 1996.
23. 1-adrenoceptor classification. Br. J. Pharmacol., 121: 1127, 1997.
24. Carruthers, S. G.: Adverse effects of alpha 1-adrenergic blocking drugs. Drug Safety, 11: 12, 1994.
25. 2-adrenoceptor subtypes: therapeutic implications. Exp. Opin. Invest. Drugs, 6: 367, 1997.
26. 1a-adrenoceptor subtype in the rat, monkey, and human urinary bladder and prostate. J. Urol., 157: 1032, 1997.
27. Zinn, K., DiMaio, D. and Maniatis, T.: Identification of two distinct regulatory regions adjacent to the human β-interferon gene. Cell, 34: 865, 1983.
28. Scofield, M.: Quantification of steady state expression of mRNA for alpha-1 adrenergic receptor subtypes using reverse transcription and a competitive polymerase chain reaction. J. Pharmacol. Exp. Ther., 275: 1035, 1995.
29. 1-adrenergic receptor subtype classification. Mol. Pharmacol., 46: 221, 1994.
30. 1-adrenergic receptor subtypes in human tissues: implications for human α-adrenergic physiology. Mol. Pharmacol., 45: 171, 1994.
31. Gosling, J. and Chilton, C.: The anatomy of the bladder, urethra, and pelvic floor. In: Urodynamics: Principles, Practice, and Applications. Edited by A. Mundy, T. Stephenson, and A. Wein. Churchill Livingstone: London, pp. 3-13, 1984.
32. Uvelius, B., Persson, L. and Mattiasson, A.: Smooth muscle cell hypertrophy and hyperplasia in the rat detrusor after short-time infravesical outflow obstruction. J. Urol., 131: 173, 1994.
33. Rosier, P. F., de Wildt, M. J., de la Rosette, J. J., Debruyne, F. M. and Wijkstra, H.: Dynamics of micturition in benign prostatic hypertrophy patients with compensated obstruction of the vesical outlet: a denervation supersensitivity-related energy-saving mechanism. J. Urol., 146: 1348, 1991.
34. Christensen, M. M. and Bruskewitz, R. C.: Clinical manifestations of benign prostatic hyperplasia and indications for therapeutic intervention. Urol. Clin. N. Am., 17: 509, 1990.
35. Abrams, P.: Benign prostatic hyperplasia poorly correlated with symptoms. Brit. Med. J., 307: 201, 1993.
36. Andersen, J. T., Nordling, J. and Walter, S.: Prostatism: the correlation between symptoms, cystometric, and urodynamic findings. Scand. J. Urol. Nephrol., 13: 229, 1979.
37. Restorick, J. M. and Mundy, A. R.: The density of cholinergic and alpha and beta adrenergic receptors in the normal and hyperreflexic human detrusor. Br. J. Urol., 63: 32, 1989.
38. Lepor, H., Nieder, A., Feser, J., O'Connell, C. and Dixon, C.: Effect of terazosin on prostatism in men with normal and abnormal peak urinary flow rates. Urology, 49: 476, 1997.
39. 1-adrenergic receptor subtypes. Prostate, 33: 55, 1997.